Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Turning Face Perception on Its Head
      • Safeguarding a Second Chance at Life
      • A Biological Betrayal
      • How to Feast for Your Eyes
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
        • Earl Stadtman Investigator Frequently Asked Questions
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
I am Intramural Blog

Melissa Glim

Melissa Glim, M.P.H., is a science writer and healthcare communications professional working with NIH’s Intramural Research Program to promote the innovative research being done at the NIH’s 27 Institutes and Centers and the scientists who are making it happen. Melissa has written about topics from Alzheimer’s disease to women’s health, covering basic science to patient education to policy and advocacy.

She supports a variety of clients from government, non-profit, and industry in strategic communications planning and implementation, coalition and partnership building, stakeholder education and outreach, and health and science writing and materials development. She has developed and led grassroots programs for Hadassah and the National Coalition for Cancer Survivorship, spoken on stem cell research and cancer survivorship advocacy at numerous conferences, created a web-based advocacy training program, and contributed a chapter to the Oncology Nursing Society’s textbook, Cancer Rehabilitation and Survivorship: Transdisciplinary Approaches to Personalized Care. Melissa has won three National Health Information awards for her articles. She received her Master of Public Health in Community Health Education from Hunter College School of Public Health and her Bachelor of Science in Science Communication from Cornell University.

In her spare time, Melissa loves making hats and jewelry, swing dancing, and writing the occasional children’s book, although most of the time, she’s waiting upon her beloved fox terrier, Tilly.


Posts By This Author

Creating Cutting-Edge Cancer Vaccines

IRP Research Identifies a Tantalizing Target for Cancer Immunotherapy

Wednesday, February 1, 2023

person getting vaccine injection

February 4 is World Cancer Day, a time to mark international efforts to prevent, detect, and treat cancer. Immunotherapy, one of the most significant advances in treating cancer, was pioneered here at NIH more than 30 years ago. Today, IRP senior investigator Claudia M. Palena, Ph.D., is pushing cancer immunotherapy forward with the discovery of a novel target for cancer vaccines.

IRP’s Bruce Tromberg Elected to National Academy of Medicine

Advances in Bioengineering Drive Life-Saving Medicine

Wednesday, January 18, 2023

Dr. Bruce Tromberg

“To discover new things, you need new ways to see them,” says Bruce J. Tromberg, Ph.D., Director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). That’s why he has spent the past 30 years of his career improving and inventing tools to help doctors and scientists conduct cutting-edge biomedical research and apply their findings to the task of saving lives. This past October, Dr. Tromberg was elected to the National Academy of Medicine (NAM) for his contributions to the fields of biophotonics and biomedical optics, as well as his leadership in the biomedical engineering and imaging community.

IRP’s Eugene Koonin Elected to National Academy of Medicine

Scientist Decoded DNA to Build a Genomic Tree of Life

Wednesday, December 14, 2022

Dr. Eugene Koonin

In 1973, the geneticist Theodosius Dobzhansky wrote a now-famous essay that declared, “Nothing in biology makes sense except in the light of evolution.” That sentiment has served as the guiding principle for the career of IRP senior investigator Eugene V. Koonin, Ph.D., who was elected to the National Academy of Medicine (NAM) in October 2022 for his contributions to the field of evolutionary biology.

Dr. Koonin’s pioneering efforts to identify clusters of similar genes found in different organisms passed down by a common ancestor — known as ‘homologous’ genes — has helped to unlock the secrets encoded in DNA and create a foundation for the systematic study of how genes evolve and function. His lab at the National Library of Medicine’s National Center for Biotechnology Information (NCBI) uses a combination of genomic sequencing and mathematical modeling to compare genes across species and determine how they work and where they came from. From this information, his team can develop a systematic framework to show the relationship between genes as they evolved. It’s like drawing the tree of life, but on a genomic scale.

Predicting Risks and Benefits for Lung Cancer Screening

IRP Researchers Refine Tools to Maximize the Benefit from Life-Saving Tests

Wednesday, November 16, 2022

patient getting a CT scan

Eleven years ago, IRP senior investigator Hormuzd Katki, Ph.D., had a bit of an eureka moment during a press event announcing the results of the National Lung Cancer Screening Trial, which demonstrated that annual screenings cut the risks of dying from lung cancer in heavy smokers by 20 percent.

“It struck me as I read the trial results that not only was this a very important trial, but that it was possible that different people will have different benefits from lung cancer screening,” Dr. Katki remembers. “Even within this group of very high-risk smokers who were part of the trial, you can identify some people who get much more benefit than other people, and that has implications for who should be offered this kind of screening.”

Simple Blood Test May Thwart a Complicated Cancer

Signs of Past Viral Exposure Predict Liver Cancer Risk

Monday, October 24, 2022

vials containing blood samples

The liver has a difficult but important job. It serves as the central processing plant for all the food, drinks, and drugs we take in, separating and breaking them down into usable nutrients and toxic wastes that need to be removed from the body. It’s no surprise, then, that diseases affecting the liver can have life-threatening consequences. In particular, infections like hepatitis B and C and liver damage caused by alcohol, drugs, or fatty liver disease can all lead to liver cancer. Unfortunately, even though the presence of these conditions are harbingers of possible liver cancer, the disease often passes unnoticed until it is at an advanced, less treatable stage.

IRP senior investigator Xin Wei Wang, Ph.D., and his NIH research team are developing ways to detect liver cancers much earlier, when existing treatments are much more likely to stop their growth. In honor of Liver Cancer Awareness Month this October, I talked to Dr. Wang about his research and the novel blood test his lab has developed to predict liver cancer risk.

A Year of Honors for IRP Cancer Researchers

Four NIH Scientists Received Prestigious Recognition in 2022

Wednesday, October 19, 2022

clockwise from top-left: Dr. Michael Lichten, Dr. Susan Lea, Dr. Kandice Tanner, and Dr. Deborah Morrison

The complexities of cancer, which is actually a collection of many diseases, has made conquering it an enormous challenge. Fortunately, researchers in the NIH Intramural Research Program are up to the task. This year, four IRP investigators in NIH’s National Cancer Institute (NCI) have been recognized for their groundbreaking contributions to answering fundamental questions about the disease and the immune system’s response to similar threats.

Bringing Out the Big Guns Against Blood Cancer

IRP Research Shows Benefits of More Intensive Treatments for Certain Patients

Wednesday, September 28, 2022

woman receiving chemotherapy treatment

Fate can be cruel, especially when it comes to a rare, highly fatal blood cancer called acute myeloid leukemia (AML). Even when months of intensive chemotherapy appear to cause a complete remission of the disease — meaning doctors cannot detect any remaining cancer cells in a patient’s body — roughly half of those patients see the cancer return within two years, or even as soon as six months. Sadly, most of them don’t survive their second bout with the disease.

As a medical student, IRP senior investigator Christopher Hourigan, M.D., D.Phil., thought this outcome was unfair. More than that, he thought it indicated that the standard ways doctors determined if an AML patient was in remission were inadequate, and that remission might not even be the right goal. That’s why he has focused his career on finding ways to detect, prevent, and treat AML recurrence, known in his field as ‘relapse’.

“I was a scientist before I became a doctor, and it was really eye-opening to me, when I started to practice medicine, how difficult some of the treatment decisions were and how limited the information available was to inform those decisions,” Dr. Hourigan says.

Research Helps Guide Families Safely Through Pandemic

IRP’s Diana Bianchi Honored for Leading Pediatric COVID Response

Monday, August 29, 2022

Dr. Diana Bianchi

When the first reports of COVID-19 came out, infectious disease experts and healthcare providers thought children might be spared its most dire effects. After all, the news reports and health statistics showed that nearly all serious cases occurred in the elderly, people with certain pre-existing conditions, and those who spent their days and nights caring for COVID patients. However, as case counts rose and disruptions in daily life grew, the medical and psychological effects of COVID on children became apparent — and the impact was alarming. It soon became clear that something had to be done to understand the disease's effects on infants, children and teens, as well as pregnant women and traditionally underserved communities.

It was, appropriately, Mother’s Day when then-NIH Director Francis Collins sought help from Diana W. Bianchi, M.D., Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and a senior investigator in the National Human Genome Research Institute (NHGRI). An expert in infant health and genetic conditions like Down syndrome, Dr. Bianchi was just the person to initiate large-scale studies across the country to assess the severity of COVID in specific populations, the safety and efficacy of vaccination and treatment, and the impact of mitigation efforts such as masking. For this critical leadership, Dr. Bianchi was named a finalist for the 2022 Samuel J. Heyman Service to America Medal for COVID-19 Response.

Understanding the Foundations of Immune Defenses

IRP’s Mary Carrington Elected to the American Academy of Arts and Sciences for Insights Into Immune System Variations

Wednesday, August 10, 2022

Dr. Mary Carrington

Some people never seem to get sick, while others catch a new bug of some sort every other week. Humans are immensely variable both in their capacity to shrug off illness and in the ways their bodies respond to medical treatments. IRP senior investigator Mary Carrington, Ph.D., has spent her entire career exploring the biological roots of these differences, and the discoveries she has made earned her election to the American Academy of Arts and Sciences earlier this year.

Leading the Charge Against Infectious Disease

Government Awards Recognize H. Clifford Lane’s Four Decades of Research Achievements

Wednesday, July 27, 2022

Dr. H. Clifford Lane

The remarkable career of H. Clifford Lane, M.D., might have gone very differently if a NIH scientist hadn’t accidentally eavesdropped on Dr. Lane’s conversation with a colleague in 1979. After hearing Dr. Lane mention that he had missed the deadline to apply for a position at NIH, the NIH researcher made some calls and discovered a spot there had just opened up — one that was perfect for Dr. Lane, who would spend the ensuing decades conducting life-saving research to understand and combat some of the world’s most dangerous infectious diseases.

Now the Clinical Director at the National Institute for Allergy and Infectious Disease (NIAID), Dr. Lane has been named a finalist for the 2022 Samuel J. Heyman Service to America Medals’ Career Achievement Award in recognition of his crucial contributions to the fight against HIV/AIDS, Ebola, COVID-19, and other illnesses. Also known as the “Sammies,” the awards recognize federal employees who are “breaking down barriers, overcoming huge challenges, and getting results.”

  • Current page1
  • Page 22
  • Page 33
  • Page 44
  • Page 55
  • Next pageNext ›
  • Last pageLast »

This page was last updated on Thursday, January 20, 2022

Blog menu

  • Contributing Authors
    • Michael Gottesman
    • Alex Szatmary
    • Alison Jane Martingano
    • Andy Baxevanis
    • Angie Abraham
    • Ashleigh LoVette
    • Ben Chambers
    • Brandon Levy
    • Brooke Worthing
    • Bruce Tromberg
    • Christophe Marchand
    • Christopher Marcum
    • Craig Myrum
    • Devon Valera
    • Dianne Lee
    • Elizabeth Burke
    • Francis Collins
    • Gabrielle Barr
    • Hoo-Chang Shin
    • Howard Young
    • James Gulley
    • Jeanelle Spencer
    • Jennifer Patterson-West
    • Jessica Pierce
    • Johnetta Saygbe
    • Karen Usdin
    • Kiara Palmer
    • L. Michelle Bennett
    • Lindsey Jay
    • Lucy Bauer
    • Lucy Kotlyanskaya
    • Melissa Glim
    • Michele Lyons
    • Mohor Sengupta
    • Noah Victoria
    • Richard Leapman
    • Robin Arnette
    • Robin Stanley
    • Sara Lioi
    • Simona Patange
    • Swagata Basu
    • Tom Misteli
    • Valerie Bonham
    • Victoria Chiou
    • Yannis Grammatikakis
    • IRP Staff Blogger
  • Categories
    • Collaboration
    • Science
    • Resources
    • Making a Difference
    • Careers

Blog links

  • Subscribe to RSS feed

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search